Crossmark

A randomised phase II trial to examine feasibility of standardised, early palliative (STEP) care for patients with advanced cancer and their families [ACTRN12617000534381]: a research protocol

Crossref DOI link: https://doi.org/10.1186/s40814-019-0424-7

Published Online: 2019-03-14

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Philip, Jennifer https://orcid.org/0000-0002-3312-0645
Collins, Anna

Le, Brian

Sundararajan, Vijaya

Brand, Caroline

Hanson, Susan

Emery, Jon

Hudson, Peter

Mileshkin, Linda

Ganiatsas, Soula
Funding

Funding for this research was provided by:

Victorian Cancer Agency
License Information

Text and Data Mining valid from 2019-03-14
More Information

Article History

Received: 11 September 2018

Accepted: 24 February 2019

First Online: 14 March 2019

Ethics approval and consent to participate

: Central ethical approval for the trial conduct at all participating sites was provided by the Human Research Ethics Committee at St Vincent’s Hospital Melbourne [HREC 179/16].

: Not applicable

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Document is current

Any future updates will be listed below